Stocks have been experiencing unusual volatility after earnings reports, sparking concerns about a possible pullback in the market. Experts predict ...
T2 Biosystems has received FDA clearance to update its T2Bacteria Panel, expanding its coverage of sepsis-causing pathogens and potentially leading ...